PreveCeutical Announces Advance in the Formulation and Biological Delivery of Therapy for Diabetes and Obesity
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2020) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), is...